Stockreport

Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference [Yahoo! Finance]

Bioventus Inc. - Class A  (BVS) 
PDF EBITDA expansion and over $100M of operating cash flow in the last two years, while reducing debt to below $300M and leverage to Management will invest disproportiona [Read more]